GlaxoSmithKline is recalling prescription-only versions of its heartburn medicine Zantac globally after the U.S. Food and Drug Administration found “unacceptable” levels of a potential carcinogen in ...

Drugmaker GSK said Wednesday it would invest $30 billion in U.S. research and development and supply chain infrastructure ...

Most Americans would be happy to pay less — a lot less — for their prescription medications. KFF research found that six in ...

President Donald Trump wants drugmakers to lower their prices in the US — so he’ll push them to raise prices in other ...

The global acetaminophen market is set to grow at a CAGR of 4.5% from 2025-2033, driven by continued demand for OTC pain relief and expanding access to essential medicines. Widely used across age ...

Pharma giant GlaxoSmithKline on Tuesday announced a deal to buy Canadian biotech Bellus Health for $2 billion, betting big on the firm’s cough medicine as it moves to shore up its slender drug ...